NEOG
NEOGEN CORP
Key Financials
Operating Income
$-1060997000
↓ 1908.6%
Net Income
$-1092044000
↓ 11491.6%
Revenue
$894.7M
↓ 3.2%
Gross Profit
$421.4M
↓ 9.2%
EPS (Diluted)
$-5.03
↓ 12475.0%
Shareholders' Equity
$2.1B
↓ 34.1%
Total Assets
$3.4B
↓ 24.3%
Total Liabilities
$1.4B
↓ 2.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NEOG |
| Company Name | NEOGEN CORP |
| CIK | 711377 |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| State of Incorporation | MI |
| Phone | 5173729200 |